Retatrutid 40mg (R&D Only)

Retatrutide 40mg pre filled research formulation – high-purity synthetic triple receptor agonist. This product is produced using a validated solid-phase synthesis process and strict GMP quality control. The purity is ≥ 98% (typical batch>99%) analyzed by RP-HPLC, and the molecular weight and sequence integrity are confirmed by high-resolution LC-MS to ensure high consistency and long-term stability between batches. Delivered in the form of sealed pre filled research pens, with a fixed capacity design to reduce manual preparation errors, supporting precise in vitro/cellular level compound stability testing, formulation development, and delivery system evaluation (such as permeability and release kinetics studies). Each research kit includes:

1 pre filled research pen (40mg Retatrutide, high-purity synthetic peptide) ‍
Detailed research information sheet (Aluvi Healthcare, providing physical and chemical parameters, recommended laboratory operation guidelines, and example COA references)

Storage conditions:
Unopened products should be refrigerated and stored at 2-8 ° C to avoid freezing and maintain molecular integrity. Suggest using under recommended conditions to ensure data reliability. Important research statement:
For laboratory research purposes only. This product is not suitable for any non research purposes. All operations must comply with the Institutional Review Board (IRB) and local laws and regulations. We provide transparent analytical data support for the research team (HPLC chromatograms, MS spectra, and COA can be provided as needed). ‍